As discussions about the potential roles in a second Trump administration heat up, Robert F. Kennedy Jr. emerges as a prominent figure in reshaping U.S. public health policy. Trump has hinted at giving RFK Jr. substantial control over health agencies, with plans that may include eliminating entire FDA departments and addressing issues surrounding vaccines and fluoride. While RFK Jr. advocates for a health agenda that challenges conventional views, including skepticism towards vaccines, experts express concern over the potential implications of such changes. The possibility of RFK Jr. influencing public health standards has sparked debates and worries within the biotech industry, illustrating the contentious landscape of health policy ahead.